Novanta (NOVT), a medicine and manufacturing technology provider, is set to report earnings on Tuesday. Last quarter, Novanta exceeded revenue expectations but missed EBITDA estimates. For the upcoming quarter, analysts anticipate a 9.5% year-on-year revenue growth, and the company’s stock has seen positive sentiment, trading up 6.2% over the last month.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Novanta Earnings: What To Look For From NOVT
Novanta (NOVT), a medicine and manufacturing technology provider, is set to report earnings on Tuesday. Last quarter, Novanta exceeded revenue expectations but missed EBITDA estimates. For the upcoming quarter, analysts anticipate a 9.5% year-on-year revenue growth, and the company’s stock has seen positive sentiment, trading up 6.2% over the last month.